<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02910856</url>
  </required_header>
  <id_info>
    <org_study_id>PSS 2014/ELDERL-IE-SELTON/SR</org_study_id>
    <nct_id>NCT02910856</nct_id>
  </id_info>
  <brief_title>Infective Endocarditis in the Elderly</brief_title>
  <acronym>ELDERL-IE</acronym>
  <official_title>Infective Endocarditis in the Elderly: Description of the Geriatric Characteristics and Their Influence on Therapeutic Care and the Morbidity and Mortality at 3 Months (ELDERL-IE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation CÅ“ur et Recherche</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ELDERL-IE is a multicenter national prospective observational study.

      The main objective is to describe geriatric characteristics (comorbidities, cognitive status,
      autonomy, nutritional status, balance and walking) in patients aged 75 years or older with
      infective endocarditis (IE).

      The secondary objectives are to assess the impact of geriatric features on the medico -
      surgical care and on morbidity and mortality at 3 months after the end of the
      hospitalization, and to describe the initial clinical presentation and diagnostic modalities
      in the IE elderly.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Population monitoring:

      Clinical, therapeutic, biological, microbiological, echocardiographic and geriatric data are
      collected. (M-2/3 before inclusion; D-15 before inclusion; D0; M3; vital status at 1 year)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline geriatric characteristics at 3 months</measure>
    <time_frame>3 months after inclusion</time_frame>
    <description>OMS score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Three months mortality</measure>
    <time_frame>3 months after inclusion</time_frame>
    <description>Mortality rate at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One year mortality</measure>
    <time_frame>1 year after inclusion</time_frame>
    <description>Mortality rate at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline geriatric characteristics at 3 months</measure>
    <time_frame>3 months after inclusion</time_frame>
    <description>Karnofsky'score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline geriatric characteristics at 3 months</measure>
    <time_frame>3 months after inclusion</time_frame>
    <description>Score MNA</description>
  </secondary_outcome>
  <enrollment type="Actual">120</enrollment>
  <condition>Infective Endocarditis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients older than 75 years are eligible if they are considered and treated as a case
        of IE by physicians ensuring their medical care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria :

          -  all patients older than 75 years are eligible if they are considered and treated as a
             case of IE by physicians ensuring their medical care.

          -  the patient should be treated in one of the clinical sites participating at the study.

          -  the patient should benefit during initial hospitalization of a geriatric assessment,
             in addition to the usual clinical and therapeutic management of such patients.

        Exclusion criteria :

          -  patients not fulfilling the criteria of definite or possible endocarditis according to
             Duke modified by Li diagnostic classification that will be applied after collection of
             all the data at the discharge of the patient.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Selton-Suty, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital, Nancy, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Hospital - University Hospital</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Forestier E, Fraisse T, Roubaud-Baudron C, Selton-Suty C, Pagani L. Managing infective endocarditis in the elderly: new issues for an old disease. Clin Interv Aging. 2016 Sep 2;11:1199-206. doi: 10.2147/CIA.S101902. eCollection 2016. Review.</citation>
    <PMID>27621607</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>September 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2016</study_first_posted>
  <last_update_submitted>January 30, 2019</last_update_submitted>
  <last_update_submitted_qc>January 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Christine Selton-Suty</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endocarditis, Bacterial</mesh_term>
    <mesh_term>Endocarditis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

